ALEAF is just getting started. Once ALEAF gets listed on NASDAQ, big institutional investors will drive the price of ALEAF to the range of $7.50-$10 range. ALEAF is low floater with huge upside.
Up-Listing to NASDAQ to Provide Greater Exposure to U.S. Investors
TORONTO, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) (“Aleafia“) or (the “Company“), one of Canada’s leading, vertically integrated cannabis companies, is announcing that it has submitted a finalized application to list its common shares on the NASDAQ.
Listing on a major United States stock exchange will provide unparalleled liquidity and place Aleafia among a small handful of Canadian cannabis companies. The U.S. based NASDAQ stock market is the second largest stock exchange by market capitalization.
Aleafia also intends to submit a Form 40-F, a requirement for Canadian companies to register securities it intends to offer on U.S. markets, to the Securities and Exchange Commission (SEC) later this week. The listing remains subject to NASDAQ and SEC approval.
“Listing on the NASDAQ is another step as we continue to execute on our stated goal of attaining a global leadership position in the cannabis space,” said Aleafia Chairman Julian Fantino.
“Management believes that listing on the NASDAQ will help to broaden our shareholder base, increase appeal to institutional investors, provide shareholders with better liquidity and, ultimately increase shareholder value, allowing Aleafia to rapidly accelerate our business strategy,” said Aleafia CEO Geoffrey Benic.
Aleafia’s common shares will continue to trade on the OTCQB under the ticker symbol “ALEAF” until NASDAQ approval and up-listing. Aleafia’s common shares will also continue to trade on the TSX Venture Exchange ("TSXV") under the ticker symbol "ALEF" post-NASDAQ up-listing.
Aleafia Highlights:
-160,000 sq. ft. Niagara greenhouse retrofitting on schedule and expected to be complete in late 2018
-Fully funded annual growing capacity of 38,000 kg of cannabis flower to be reached in 2019
-Signed supply MOU with CannTrust Holdings Inc. for up 15,000 kg of cannabis in 2019
-Planning of Aleafia’s Port Perry expansion underway, with all production options on the table, including an innovative, ultra low-cost outdoor grow
-Reached milestone of 50,000 medical cannabis patients
-Secured first medical cannabis sale in company’s history, only days after securing Sales Licence from Health Canada
-Added to Horizons Marijuana Life Sciences ETF, the largest cannabis ETF in the world
